000 01195 a2200313 4500
005 20250516090634.0
264 0 _c20130121
008 201301s 0 0 eng d
022 _a1029-2403
024 7 _a10.3109/10428194.2012.676177
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aJoerger, M
245 0 0 _aRational administration schedule for high-dose methotrexate in patients with primary central nervous system lymphoma.
_h[electronic resource]
260 _bLeukemia & lymphoma
_cOct 2012
300 _a1867-75 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAntimetabolites, Antineoplastic
_xadministration & dosage
650 0 4 _aCentral Nervous System Neoplasms
_xdrug therapy
650 0 4 _aDrug Administration Schedule
650 0 4 _aHumans
650 0 4 _aLymphoma, Non-Hodgkin
_xdrug therapy
650 0 4 _aMethotrexate
_xadministration & dosage
650 0 4 _aTreatment Outcome
700 1 _aHuitema, A D R
700 1 _aIllerhaus, G
700 1 _aFerreri, A J M
773 0 _tLeukemia & lymphoma
_gvol. 53
_gno. 10
_gp. 1867-75
856 4 0 _uhttps://doi.org/10.3109/10428194.2012.676177
_zAvailable from publisher's website
999 _c21728897
_d21728897